Nominations are now being accepted for the Purdue HTM Hall of Fame Award, one of the highest honors bestowed by the White Lodging–J.W. Marriott, Jr. School of Hospitality and Tourism Management ...
Abstract: Refactoring is crucial for maintaining a project, but it requires developers to understand code structure and system design principles well. Recent research on Large Language Models(LLMs) ...
Visual Studio Code 1.108 adds experimental Agent Skills, allowing GitHub Copilot to load custom instructions, scripts, and resources for specialized tasks. Agent Skills are defined in a simple folder ...
Banks are racing to understand how generative AI can transform their operations, yet most institutions remain constrained by decades‑old legacy systems, fragmented data, and risk‑averse governance ...
Atlanta-based rapper J.I.D. is officially preparing for the biggest run of his career with the announcement of his 2025-2026 "God Does Like World Tours." The newly announced tour has been designed to ...
In the evolving history of software development, a quiet revolution is unfolding, one that blends artificial intelligence with environmental responsibility. As computing power drives innovation, it ...
Anthropic released its most capable artificial intelligence model yet on Monday, slashing prices by roughly two-thirds while claiming state-of-the-art performance on software engineering tasks — a ...
James Donald Vance Jr., of Grand Rapids, Mich., had also threatened President Trump, according to a criminal complaint. By Neil Vigdor Their initials match. So do their surnames. One is a heartbeat ...
OpenAI has introduced GPT-5-Codex-Mini, a cost-efficient model offering 4x the usage with only a minor drop in performance. Back in September, OpenAI announced GPT-5-Codex, a new GPT-5 model that is ...
CEO Elizabeth Barrett highlighted the progress of the ZUSDURI launch and noted, "The preliminary demand revenue for October is more than double the previous 3 months, demonstrating increased usage and ...
CLEVELAND, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a commercial-stage biopharmaceutical company developing cell and gene therapies for serious diseases, today ...